14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CEMP
Delisted

Cempra Fund Price (Quote)

$2.33
+0 (+0%)
At Close: Jan 16, 2018

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 16th Jan 2018 CEMP stock ended at $2.33. During the day the stock fluctuated 0% from a day low at $2.33 to a day high of $2.33.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Cempra prices

Date Open High Low Close Volume
Jan 16, 2018 $2.33 $2.33 $2.33 $2.33 0
Jan 15, 2018 $2.33 $2.33 $2.33 $2.33 0
Jan 12, 2018 $2.33 $2.33 $2.33 $2.33 0
Jan 11, 2018 $2.33 $2.33 $2.33 $2.33 0
Jan 10, 2018 $2.33 $2.33 $2.33 $2.33 0
Jan 09, 2018 $2.33 $2.33 $2.33 $2.33 0
Jan 08, 2018 $2.33 $2.33 $2.33 $2.33 0
Jan 05, 2018 $2.33 $2.33 $2.33 $2.33 0
Jan 04, 2018 $2.33 $2.33 $2.33 $2.33 0
Jan 03, 2018 $2.33 $2.33 $2.33 $2.33 0
Jan 02, 2018 $2.33 $2.33 $2.33 $2.33 0
Dec 29, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 28, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 27, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 22, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 21, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 20, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 19, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 18, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 15, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 14, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 13, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 12, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 11, 2017 $2.33 $2.33 $2.33 $2.33 0
Dec 08, 2017 $2.33 $2.33 $2.33 $2.33 0
Click to get the best stock tips daily for free!

About Cempra

Cempra, Inc., a clinical-stage pharmaceutical company, focuses on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases in North America. Its lead product candidates include solithromycin (CEM-101), which is in Phase III clinical trials for the treatment of community acquired bacterial pneumonia, as well as for uncomplicated bacterial urethritis; and Taksta, an antibiotic that has completed Phase II clinic... CEMP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT